Blazing, Michael A <br/><br/>
On-treatment analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT).  [electronic resource] 

 -  American heart journal  Dec 2016 
 - 89-96 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1097-6744 
<br/><br/><label>Standard No.: </label>10.1016/j.ahj.2016.09.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--blood<br/>Aged<br/>Anticholesteremic Agents--administration & dosage<br/>Cholesterol, LDL--blood<br/>Dose-Response Relationship, Drug<br/>Drug Monitoring--methods<br/>Drug Synergism<br/>Drug Therapy, Combination--methods<br/>Ezetimibe--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Simvastatin--administration & dosage<br/>Treatment Outcome